norfloxacin has been researched along with ENT Diseases in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murai, K | 1 |
| Baba, S | 1 |
1 other study available for norfloxacin and ENT Diseases
| Article | Year |
|---|---|
Studies on distribution of two nalidixic acid analogs in otorhinolaryngological field.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Otorhi | 1982 |